Fund Holdings — SR ONE CAPITAL MANAGEMENT, LP

Total Portfolio Value:
$1.15B
Total Bought:
$219.28M
Total Sold:
$44.41M
Net Transaction:
+$174.87M
Notable People:
Sr One Capital Management, Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Veradermics, Incorporated(MANE)2,401,8682,080,119-321,749$295.29M$252.17M21.94%-$43.11M
ADARx Pharmaceuticals, Inc.09,936,661+9,936,661$0$198.14M17.24%+$198.14M
Zenas BioPharma, Inc.(ZBIO)5,037,8545,037,8540$127.86M$135.87M11.82%+$8.01M
CRISPR Therapeutics AGNAMEN AKT(CRSP)2,038,7632,038,7630$111.19M$112.78M9.81%+$1.59M
Avalyn Pharma, Inc3,308,6493,308,6490$108.92M$94.26M8.20%-$14.66M
Odyssey Therapeutics, Inc.3,794,8833,794,8830$71.00M$84.32M7.34%+$13.32M
Design Therapeutics, Inc.6,526,4766,526,4760$94.44M$82.04M7.14%-$12.40M
ORIC Pharmaceuticals, Inc.4,615,3844,615,3840$49.98M$62.17M5.41%+$12.18M
Mineralys Therapeutics, Inc.(MLYS)1,563,9661,563,9660$42.20M$39.30M3.42%-$2.89M
Korsana Biosciences, Inc.0613,915+613,915$0$19.65M1.71%+$19.65M
Mobia Medical, Inc1,986,0721,986,0720$26.61M$18.77M1.63%-$7.84M
ARS Pharmaceuticals, Inc.4,012,9034,012,9030$32.14M$17.30M1.50%-$14.85M
Alumis Inc.1,959,8961,959,8960$55.15M$14.48M1.26%-$40.67M
Nkarta, Inc.3,333,3333,333,3330$9.43M$8.73M0.76%-$700.0K
Oculis Holding AG641,022641,0220$8.89M$5.99M0.52%-$2.90M
Ultragenyx Pharmaceutical Inc.(RARE)137,753137,7530$4.60M$2.07M0.18%-$2.53M
enGene Therapeutics Inc.0747,750+747,750$0$1.50M0.13%+$1.50M
enGene Holdings Inc.
COM
747,7500-747,750$1.29M$0—-$1.29M
Page 1 of 1
SR ONE CAPITAL MANAGEMENT, LP — 13F Holdings — Q3 2026 | TickerTrail